CODX vs WAT
Co-Diagnostics, Inc. Common Stock (CODX) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported WAT revenue for 2024-12-31 was $872.7M. Net income was $637.8M. Revenue was up 17.9% from 2024-09-30 to 2024-12-31. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
CODX currently screens at market cap $31.4M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the CODX and WAT stock pages for the full models.
Not investment advice.